The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 8, 2003, Pages 3501-3504

  Souberbielle, Jean Claude ^a,d   Lawson Body, Ethel ^a   Hammadi, Boualem ^a   Sarfati, Emile ^c   Kahan, Andrè ^b   Cormier, Catherine ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Hôpital Cochin ^*  (France)

^c SAINT LOUIS HOSPITAL   (France)

^d Centre d'Explorations Fonctionnelles Otoneurologiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; FUROSEMIDE; GLUCOCORTICOID; LITHIUM; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

ADULT; AGED; ARTICLE; BONE MASS; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; CONCENTRATION RESPONSE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; PARATHYROID HORMONE BLOOD LEVEL; PATIENT SELECTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REFERENCE VALUE; STATISTICAL ANALYSIS; VALIDATION PROCESS; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ADULT; AGED; BONE DISEASES, METABOLIC; CALCIUM; DIPHOSPHONATES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; REFERENCE VALUES; VITAMIN D;

EID: 0041382668     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030097     Document Type: Article

References (34)

1. Sahota O, Masud T, San P, Hosking DJ 1999 Vitamin D insufficiency increases bone turnover at the hip in patients with established vertebral osteoporosis. Clin Endocrinol (Oxf) 51:217-221
2. Lips P 2001 Vitamin D deficiency ans secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501
3. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE 2001 Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 96:3086-3090
4. Nussbaum S, Zahradnik R, Lavigne J, Brennan G, Nozawa-Ung K, Kim L, Keutmann H, Wang CH, Potts J, Segre G 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367
5. Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, Bellony R, Dubreuil A 1991 Evaluation of the calcium content of diet by frequential self-questionnaire. Rev Rhum Mal Osteoartic 58:99-103
6. Pak CY, Oata M, Lawrence B, Snyder W 1974 The hypercalciurias. Causes, parathyroid functions and diagnostic criteria. J Clin Invest 54:387-400
7. Preece MA, O'Riordan JLH, Lawson DEM, Kodicek E 1974 A competitive protein binding assay for 25-hydroxycholecalciferol in serum. Clin Chem Acta 54:235-242
8. Shepard RM, Horst RL, Hamstra AJ, De Luca HF 1979 Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J 182:55-69
9. Bilezikian J, Potts J, El-Hadj Fulheihan G, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg S, Udelsman R, Wells S 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353-5361
10. Consensus Development Conference Panel 1991 Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114:593-597
11. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinsky R, Meier D, Luckey M 2002 Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431-4437
12. Bileziklan J, Potts J 2002 Asymptomatic primary hyperparathyroidism: new issues and new questions - bridging the past with the future. J Bone Miner Res 17(Suppl 2):N57-N67
13. Aris R, Ontjes D, Buell H, Blackwood A, Lark R, Caminiti M, Brown S, Rennet J, Chalermskulrat W, Lester G 2002 Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 13:151-157
14. Nuti R, Martini G, Valenti R, Giovani S, Salvatori S, Avanzati A 2001 Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 250:361-366
15. Fraser W, Logue F, MasRitchie K, Wilson R, Gray H, Beastall G, O'Reilly D 1991 Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease. Acta Endocrinol (Copenh) 124:652-657
16. Misael da Silva AM, Dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V 2002 Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183-191
17. Valimaki M, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lambert-Allardt C, Makela P, Tunninen R 1994 Bone mineral density measured by dual x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 9:631-637
18. Stein MS, Scherer SC, Walton SL, Gilbert R, Ebeling P, Flicker L, Wark J 1996 Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol (Oxf) 44:375-383
19. Haden S, Stoll A, McCormick S, Scott J, Fuleihan G el-H 1997 Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab 82:2844-2848
20. Vasikaran SD 2001 Bisphosphonates: an overview with special reference to alendronate. Ann Clin Biochem 38:608-623
21. Heaney R 2000 Vitamin D: how much do we need, and how much is too much? Osteoporos Int 11:553-555
22. Malabanan A, Veronikis IE, Hollick M 1998 Redefining vitamin D insufficiency. Lancet 351:805-806
23. Glendenning P, Vasikaran S 2002 Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 87:945-947 (Letter)
24. Krall E, Sayoun N, Tannenbaum S, Dallal G, Dawson-Hughes B 1989 Effect of vitamin D intake on seasonal variations in parathyroid secretion in postmenopausal women. N Engl J Med 321:1777-1783
25. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439-443
26. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick M 1999 An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9:394-397
27. Vieth R 2000 Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporos Int 11:635-636
28. Hollis BW 2000 Comparison of commercially available (125)I-based PdA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 46:1657-1661
29. Souberbielle JC, Lawson-Body E, Kindermans C 2002 Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 87:947 (Letter)
30. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary JR 1985 Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 76:470-473
31. Dawson-Hughes B, Harris SS, Finneran S, Rasmussen HM 1993 Calcium absorption responses to calcitriol in black and white premenopausal women. J Clin Endocrinol Metab 80:3068-3072
32. M'Buyamba-Kabangu JR, Fagard R, Lijnen P, Bouillon R, Lissens W, Amery A 1987 calcium, vitamin D endocrine system, and parathyroid hormone in black and white males. Calcif Tissue Int 41:70-74
33. Marcus R, Madvig P, Young G 1984 Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab 58:223-230
34. Quesada JM, Coopmans W, Ruiz B, Aljam P, Jans I, Bouillon R 1992 Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 75:494-501